22-17085108-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_014339.7(IL17RA):​c.17G>C​(p.Ser6Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000822 in 1,216,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S6N) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 8.2e-7 ( 0 hom. )

Consequence

IL17RA
NM_014339.7 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.102

Publications

0 publications found
Variant links:
Genes affected
IL17RA (HGNC:5985): (interleukin 17 receptor A) Interleukin 17A (IL17A) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. The transmembrane protein encoded by this gene (interleukin 17A receptor; IL17RA) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2014]
IL17RA Gene-Disease associations (from GenCC):
  • immunodeficiency 51
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • chronic mucocutaneous candidiasis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.043688595).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17RANM_014339.7 linkc.17G>C p.Ser6Thr missense_variant Exon 1 of 13 ENST00000319363.11 NP_055154.3 Q96F46-1
IL17RANM_001289905.2 linkc.17G>C p.Ser6Thr missense_variant Exon 1 of 12 NP_001276834.1 Q96F46-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17RAENST00000319363.11 linkc.17G>C p.Ser6Thr missense_variant Exon 1 of 13 1 NM_014339.7 ENSP00000320936.6 Q96F46-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
8.22e-7
AC:
1
AN:
1216614
Hom.:
0
Cov.:
59
AF XY:
0.00000169
AC XY:
1
AN XY:
591134
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24516
American (AMR)
AF:
0.00
AC:
0
AN:
13192
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17578
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27534
South Asian (SAS)
AF:
0.00
AC:
0
AN:
55544
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29732
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4862
European-Non Finnish (NFE)
AF:
0.00000101
AC:
1
AN:
993768
Other (OTH)
AF:
0.00
AC:
0
AN:
49888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 23, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.17G>C (p.S6T) alteration is located in exon 1 (coding exon 1) of the IL17RA gene. This alteration results from a G to C substitution at nucleotide position 17, causing the serine (S) at amino acid position 6 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
3.6
DANN
Benign
0.40
DEOGEN2
Benign
0.057
T;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.38
T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.044
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.0
N;N
PhyloP100
-0.10
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-0.13
N;.
REVEL
Benign
0.0080
Sift
Benign
0.76
T;.
Sift4G
Benign
0.71
T;T
Polyphen
0.033
B;.
Vest4
0.058
MutPred
0.14
Loss of glycosylation at S6 (P = 0.0641);Loss of glycosylation at S6 (P = 0.0641);
MVP
0.088
MPC
0.17
ClinPred
0.059
T
GERP RS
-0.34
PromoterAI
-0.031
Neutral
Varity_R
0.11
gMVP
0.39
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2061321130; hg19: chr22-17565998; API